Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 61 - 90 of 251
Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Olanzapin ratiopharm 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti SPC 2020-07-08

PL

Resepti

Olanzapin Ratiopharm 5 mg, 10 mg, 15 mg, 20 mg tabletti, suussa hajoava SPC 2020-09-15

PL

Resepti

Olanzapin Sandoz 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2021-01-29

PL

Resepti

Olanzapine Accord 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2022-04-26

European Medicines Agency's website:
Olanzapine Apotex - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Olanzapine Glenmark - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Olanzapine Glenmark Europe - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Olanzapine Mylan - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Olanzapine Teva - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Olazax - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Olazax Disperzi - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Oleo D3 14 400 IU-ml tipat, liuos SPC 2021-07-12

PL

Resepti

Olimel N12 infuusioneste, emulsio SPC 2020-04-29

PL

Resepti

Olimel N12E infuusioneste, emulsio SPC 2020-03-24

PL

Resepti

Olimel N5E infuusioneste, emulsio SPC 2020-05-06.docx

PL

Resepti

Olimel N7 infuusioneste, emulsio SPC 2020-05-06.docx

PL

Resepti

Olimel N7E infuusioneste, emulsio SPC 2020-05-06.docx

PL

Resepti

Olimel N9 infuusioneste, emulsio SPC 2020-05-06.docx

PL

Resepti

Olimel N9E infuusioneste, emulsio SPC 2020-05-06.docx

PL

Resepti

Olimel Perifer N4E infuusioneste, emulsio SPC 2020-05-06.docx

PL

Resepti

Olmesartan Medoxomil Accord 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2022-09-08

PL

Resepti

Olmesartan medoxomil Krka 10 mg, 20 mg, 40 mg, kalvopäällysteinen tabletti SPC 2022-09-27

PL

Resepti

Olmesartan medoxomil Sandoz 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2022-07-22

PL

Resepti

Olmesartan medoxomil Stada 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2022-02-04

PL

Resepti

Olmesartan medoxomil-Amlodipine Accord 20 mg-5 mg, 40 mg-5 mg, 40 mg-10 mg tabletti, kalvopäällysteinen SPC 2023-01-10

PL

Resepti

Olmesartan medoxomil-Amlodipine Krka 20 mg-5 mg, 40 mg-5 mg, 40 mg-10 mg tabletti, kalvopäällysteinen SPC 2022-08-24

PL

Resepti

Olmesartan Medoxomil-Hydrochlorothiazide Krka 20 mg-12.5 mg, 20 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-06-09

PL

Resepti

Olmesartan Medoxomil-Hydrochlorothiazide Krka 40 mg-12.5 mg, 40 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-06-09

PL

Resepti

Oltar 1 mg, 2 mg, 3 mg tabletti SPC 2024-01-23

European Medicines Agency's website:
Olumiant - EMA: EPAR PI
Finnish Swedish

Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >